HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Cardiologists’ and radiologists’ efforts to receive proper reimbursement for cardiac computed ...
Novo Nordisk is adding on to its cardiovascular drug pipeline with the acquisition of Cardior Pharmaceuticals, a genetic medicines developer whose lead program is in mid-stage clinical testing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback